title: [IAG regimen for patients with refractory/relapsed acute myeloid leukemia].
authors.affiliation: Key Laboratory of Thrombosis and Haemostasis, Ministry of Health, Jiangsu Institute of Hematology, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
authors.forename: Yong
authors.initials: Y
authors.lastname: Yang
authors.forename: Cheng-fu
authors.initials: CF
authors.lastname: Ji
authors.forename: Yan-ming
authors.initials: YM
authors.lastname: Zhang
authors.forename: Li-Min
authors.initials: LM
authors.lastname: Liu
authors.forename: Guang-sheng
authors.initials: GS
authors.lastname: He
authors.forename: Zheng-ming
authors.initials: ZM
authors.lastname: Jin
authors.forename: Xiao
authors.initials: X
authors.lastname: Ma
authors.forename: Sheng-li
authors.initials: SL
authors.lastname: Xue
authors.forename: Xue-feng
authors.initials: XF
authors.lastname: He
authors.forename: De-pei
authors.initials: DP
authors.lastname: Wu
authors.forename: Ai-ning
authors.initials: AN
authors.lastname: Sun
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D055815:Young Adult
chemical_list: D003561:Cytarabine; D003630:Daunorubicin